The African population is increasing rapidly. Consequently, the number of senior citizens also increases. Hence, Africa is likely to face a lot of age-related health problems in the coming 30 years. The middle-class in African countries comprise a major chunk of the modern population.

This increases the risk of heart disorders, obesity, and other lifestyle diseases. In addition to it, the tropical climate makes Africa a host of deadly infectious diseases like cholera, polio, malaria, tuberculosis, etc. As a result, improvement in the pharma sectors of African countries is the need of the hour. However, the current scenario is not very promising. Weak education and lack of qualified pharmacies are causing hindrance in the medical upliftment of African countries. The only way out is the involvement of international players. This will boost allied domestic industries, as the new entrants will need to tie-up with local businesses of manufacturing, packaging, and distribution. The result will be an improved pharmaceutical ecosystem in Africa.

The partnership of African suppliers with Indian exporters can be particularly beneficial. Indian pharma companies have the unique ability to produce high-quality generics at the most affordable prices. These generics may prove to be life-saving for the vast African population that is still living in poverty. The involvement of Indian companies will create a win-win situation for the common Africans by providing them access to all those medicines that were previously not available. With about 20% of India’s pharma exports going to African countries, Indian pharma companies become crucial for medical upliftment in Africa.